Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

italfarmaco s.p.a. - doxylamine, combinations - doxylamine, combinations

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

exeltis italia s.r.l. - doxylamine, combinations - doxylamine, combinations

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

effik sa - doxylaminum, pyridoxinum - gélule à libération modifiée - doxylamini hydrogenosuccinas 10 mg corresp. doxylaminum 7 mg, pyridoxini hydrochloridum 10 mg corresp. pyridoxinum 8.2 mg, sacchari sphaerae corresp. saccharum 49.3 - 73.1 mg, talcum, silica colloidalis anhydrica, matériel de la capsule: lacca, povidonum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, gelatina, e 132, e 104, e 171, pro capsula. - traitement symptomatique des nausées et vomissements de la grossesse (nvg) chez l'adulte qui ne répond pas au traitement conservateur - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

exeltis italia s.r.l. - doxylamine, combinations - doxylamine, combinations

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - doxylaminum - gocce - doxylaminum 10 mg ut doxylamini hydrogenosuccinas, glycerolum, aurantii amari extractum liquidum normatum, e 150d, polysorbatum 80, saccharinum natricum, chinini sulfas, anetholum, valerianae aetheroleum, simeticonum, ethanolum 96 per centum 190 mg, natrii hydroxidum, aqua purificata ad solutionem pro 1 ml corresp. 25 guttae corresp. natrium 1.7 mg, corresp. ethanolum 24 % v/v. - sedativo - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - narcolessia - altri farmaci sul sistema nervoso - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

pharmanovia a/s - oppio - oppio

Unione Europea - italiano - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - sleep apnea, obstructive - altri farmaci sul sistema nervoso - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

procter & gamble international operations sa - dextromethorphani hydrobromidum, doxylamini hydrogenosuccinas, ephedrini sulfas, paracetamolum - sciroppo - dextromethorphani hydrobromidum 50 mg, doxylamini hydrogenosuccinas 25 mg, ephedrini sulfas 26.7 mg, paracetamolum 2 g, sono, colore.: di e 104, e 132, conserv.: e 211, excipiens ad una soluzione di 100 ml corrisp. ethanolum 15 % v/v. - il freddo e il raffreddore - synthetika

Italia - italiano - Ministero della Salute

t&b technology and business -